Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cemtrex (CETXP) Research & Development (2017 - 2025)

Cemtrex's Research & Development history spans 9 years, with the latest figure at $501435.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 43.66% year-over-year to $501435.0; the TTM value through Dec 2025 reached $2.0 million, down 42.2%, while the annual FY2025 figure was $2.4 million, 29.91% down from the prior year.
  • Research & Development reached $501435.0 in Q4 2025 per CETXP's latest filing, up from $298603.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.6 million in Q1 2023 to a low of -$627723.0 in Q3 2023.
  • Average Research & Development over 5 years is $830546.9, with a median of $856644.0 recorded in 2023.
  • Peak YoY movement for Research & Development: tumbled 180.11% in 2023, then surged 210.36% in 2024.
  • A 5-year view of Research & Development shows it stood at $1.1 million in 2021, then soared by 43.37% to $1.5 million in 2022, then plummeted by 44.82% to $848805.0 in 2023, then grew by 4.86% to $890083.0 in 2024, then plummeted by 43.66% to $501435.0 in 2025.
  • Per Business Quant, the three most recent readings for CETXP's Research & Development are $501435.0 (Q4 2025), $298603.0 (Q3 2025), and $386565.0 (Q2 2025).